Literature DB >> 28693791

ETV6 and ETV7: Siblings in hematopoiesis and its disruption in disease.

Parisa Rasighaemi1, Alister C Ward2.   

Abstract

ETV6 (TEL1) and ETV7 (TEL2) are closely-related members of the ETS family of transcriptional regulators. Both ETV6 and ETV7 have been demonstrated to play key roles in hematopoiesis, particularly with regard to maintenance of hematopoietic stem cells and control of lineage-specific differentiation, with evidence of functional interactions between both proteins. ETV6 has been strongly implicated in the molecular etiology of a number of hematopoietic diseases, including as a tumor suppressor, an oncogenic fusion partner, and an important regulator of thrombopoiesis, but recent evidence has also identified ETV7 as a potential oncogene in certain malignancies. This review provides an overview of ETV6 and ETV7 and their contribution to both normal and disrupted hematopoiesis. It also highlights the key clinical implications of the growing knowledge base regarding ETV6 abnormalities with respect to prognosis and treatment.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALL; ETV6; ETV7; Hematopoiesis; Leukemia; MDS; MPD

Mesh:

Substances:

Year:  2017        PMID: 28693791     DOI: 10.1016/j.critrevonc.2017.05.011

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  8 in total

1.  Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.

Authors:  Sanghoon Lee; Yiheng Hu; Suet Kee Loo; Ying Tan; Rohit Bhargava; Michael T Lewis; Xiao-Song Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-22       Impact factor: 11.205

2.  ETV7 limits antiviral gene expression and control of influenza viruses.

Authors:  Heather M Froggatt; Alfred T Harding; Ryan R Chaparian; Nicholas S Heaton
Journal:  Sci Signal       Date:  2021-07-13       Impact factor: 8.192

Review 3.  Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.

Authors:  Suet Kee Loo; Megan E Yates; Sichun Yang; Steffi Oesterreich; Adrian V Lee; Xiao-Song Wang
Journal:  Genes Chromosomes Cancer       Date:  2022-02-17       Impact factor: 5.006

4.  Transmembrane adaptor protein WBP1L regulates CXCR4 signalling and murine haematopoiesis.

Authors:  Simon Borna; Ales Drobek; Jarmila Kralova; Daniela Glatzova; Iva Splichalova; Matej Fabisik; Jana Pokorna; Tereza Skopcova; Pavla Angelisova; Veronika Kanderova; Julia Starkova; Petr Stanek; Orest V Matveichuk; Nataliia Pavliuchenko; Katarzyna Kwiatkowska; Majd B Protty; Michael G Tomlinson; Meritxell Alberich-Jorda; Vladimir Korinek; Tomas Brdicka
Journal:  J Cell Mol Med       Date:  2019-12-17       Impact factor: 5.310

5.  NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Roderick A F MacLeod
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

6.  Combined heterozygosity of FLT3 ITD, TET2, and DNMT3A results in aggressive leukemia.

Authors:  Baskar Ramdas; Palam Lakshmi Reddy; Raghuveer Singh Mali; Santhosh Kumar Pasupuleti; Ji Zhang; Mark R Kelley; Sophie Paczesny; Chi Zhang; Reuben Kapur
Journal:  JCI Insight       Date:  2022-09-08

Review 7.  Ubiquitin-Mediated Control of ETS Transcription Factors: Roles in Cancer and Development.

Authors:  Charles Ducker; Peter E Shaw
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

8.  Immune profiling reveals prognostic genes in high-grade serous ovarian cancer.

Authors:  Yong Wu; Lingfang Xia; Ping Zhao; Yu Deng; Qinhao Guo; Jun Zhu; Xiaojun Chen; Xingzhu Ju; Xiaohua Wu
Journal:  Aging (Albany NY)       Date:  2020-06-16       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.